Our findings proved that hGAG-mediated inhibition of metastasis and procoagulant activity of B16F10 cancer cells involve MAPKs (p38 MAPK, ERK1/2)/NF-κB/TF signaling pathways. The gene discussed is MAPK3; the disease is cancer.